Press Release

Scientists from the Broad Institute of Massachusetts Institute of Technology and Harvard have developed a first-of-its-kind cross-tissue cell atlas, and in collaboration with a team of Mass Eye and Ear researchers led by Ayellet V. Segrè, PhD, MSc...

Ocugen, Inc. has obtained an exclusive worldwide license to develop and commercialize future ophthalmology products based on groundbreaking technology developed by Neena Haider, PhD, Associate Professor of Ophthalmology. Learn about this technology and...

Findings may lead to earlier diagnoses and better prognostic information for patients — and, potentially, new pharmaceutical targets for AMD treatment. Boston, Mass. — Patients with any stage of age-related macular degeneration (AMD) carry signs of the...

Boston, Mass. — Massachusetts Eye and Ear opened a new ophthalmology (eye care) practice at 578 Main Street in Malden, Mass., on March 6. Mass. Eye and Ear, Malden is the hospital’s 19 th location designed to bring the expertise of Mass. Eye and Ear...

Boston, Mass. — Researchers from Schepens Eye Research Institute of Massachusetts Eye and Ear have uncovered two factors responsible for the chronic, lifelong nature of autoimmune disorders, which tend to “flare up” intermittently in affected patients...

Boston, Mass. — Luk H. Vandenberghe, PhD, Director of the Grousbeck Gene Therapy Center at Massachusetts Eye and Ear and an Assistant Professor of Ophthalmology at Harvard Medical School, has been awarded a Nelson Trust Award for Retinitis Pigmentosa by...

Information for this release was provided by the Association for Research in Vision and Ophthalmology. Rockville, Md. — Vision scientists may have discovered how to reduce pedestrian collisions in crowded and chaotic open space environments like bus...

Ophthalmologists at Mass. Eye and Ear among the most experienced nationwide with newly FDA-approved corneal cross-linking procedure Boston, Mass. — Ophthalmologists at Massachusetts Eye and Ear are currently accepting patients who may be candidates for a...

New findings may pave the way for the development of pharmaceutical therapies to reverse corneal scarring Boston, Mass. — In cases of severe ocular trauma involving the cornea, wound healing occurs following intervention, but at the cost of opaque scar...

David A. Sullivan, PhD, in collaboration with colleagues from several institutions worldwide, evaluated the use of recombinant human lubricin – a glycoprotein with lubricating, anti-adhesive and anti-inflammatory activities – as a treatment for patients...